nialamide has been researched along with Optic Atrophy in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Optic Atrophy: Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions (see OPTIC ATROPHIES, HEREDITARY) are relatively common causes of this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GOLDBERG, LI | 1 |
| Stenkula, S | 1 |
| Wranne, I | 1 |
1 review available for nialamide and Optic Atrophy
| Article | Year |
|---|---|
MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS.
Topics: Amphetamine; Amphetamines; Chemical and Drug Induced Liver Injury; Headache; Hematologic Diseases; H | 1964 |
1 other study available for nialamide and Optic Atrophy
| Article | Year |
|---|---|
Can optic atrophy caused by pheniprazine treatment become aggravated by subsequent nialamid treatment?
Topics: Adult; Color Perception; Female; Humans; Hydrazines; Male; Middle Aged; Nialamide; Optic Atrophy; Vi | 1966 |